Serine protease inhibitors are molecules that reduce peptide-bond hydrolysis by proteases whose catalytic mechanism uses a serine residue as the nucleophile [1][2]. They include small organic compounds and inhibitory proteins with distinct binding mechanisms [1][3]. Electrophilic inhibitors can react with the catalytic serine to form covalent complexes, whereas noncovalent inhibitors obstruct substrate recognition or access to the catalytic machinery [1][2]. Serpins inhibit through a coupled cleavage and conformational rearrangement: the protease attacks an exposed reactive loop, which subsequently inserts into the inhibitor's central beta sheet. This movement displaces and distorts the tethered protease, trapping the enzyme in an inactive complex [3]. Other protein inhibitors achieve inhibition through tight binding without this extensive structural transition; tick anticoagulant peptide selectively inhibits coagulation factor Xa [4]. Recognition of residues surrounding the scissile bond and contacts outside the catalytic center contribute to selectivity, so inhibition of one serine protease does not imply equivalent inhibition of the entire enzyme family [1][4].
Protein Degradation and Inhibitors • Molecular Biology • Biochemistry, Genetics and Molecular Biology • Life Sciences